Medicines Management
COVID 19 - Patients
Frequently asked questions - Inhalers and Coronavirus
Patient Information - How to help you pharmacy
Patient FAQs ordering medicines when self isolating
How patients can order repeat prescriptions electronically
Patient FAQs on immunosuppressants
Patient Palliative Care and Specialist Medicines Leaflet
COVID 19 - Clinicians
Useful Covid 19 Resources:
Patient Group Direction (PGD) Summary for Covid 19 Vaccines
Gov UK - Covid 19 Vaccaniation Programme - Protocols and PGDs
Letter from Chief Medical Officers re UK Covid 19 Vaccination Programme – Dec 2020
Optimising the Covid 19 vaccination programme for maximum short-term impact
Guidance for Care Homes on the use of Vitamin D supplements obtained by the DHSC
https://www.rpharms.com.coronavirus
https://www.nice.org.uk/covid-19
https://www.gov.uk/government/collections/mhra-guidance-on-coronavirus-covid-10
Covid 19 Vaccine Pharmacy Communications Reference Guide
Rescue Pack for COPD and Asthma
COVID related professional advice
Remote Outpatients Clinics - Medicine Supply
Responsibility for Prescribing
NHS Volunteers Responders Information for Primary Care Professionals
How patients can order repeat prescriptions electronically
Ibuprofen and Coronavirus (COVID 19)
Police Pharmacy Advice - COVID
Shared Care Drugs Monitoring during COVID 19
Position statement for prescribing for patients abroad during Coronavirus outbreak
Ramadan Rapid Review Recommendations - Risk Table
Access to Palliative Care Drugs
Access to EOL Drugs in Primary Care during COVID 19
Webinar for the Essex arrangements for accessing EOL Medicines and your role in the re-use of medicines in care homes:
https://vimeo.com/420289598/2c9418f399
Prescription Management during COVID 19
Hospitals Group Anticoagulation Clinics
Chapter 1 - Gastro-intestinal system
Chapter 2 - Cardiovascular system
Chapter 3 - Respiratory system
Chapter 4 - Nervous System
Cannabis Products MSEMOC Position Statement
Chronic Fatigue Syndrome (CFS) or myalgic encephalomyelitis (ME)
Co-Proxamol is not supported for acute of chronic pain
EPUT formulary and shared care guidelines
Fentanyl immediate release preparation MSEMOC Position Statement
Good practice for paracetamol prescribing
Low Dose Naltrexone for the treatment of Multiple Sclerosis
Oxycodone and Naloxone MSEMOC Position Statement
Tramadol review guidance Policy for Chronic Fatigue ME
Tramadol and paracetamol MSEMOC Position Statement
Chapter 5 - Infection
Chapter 6 - Endocrine system
Chapter 7 - Genito-Urinary System
Chapter 8 - Malignant disease
Chapter 9 - Nutrition and blood
Chapter 10 - Musculoskeletal System
Chapter 11 - Eye
Chapter 12 - Ear, Nose and Oropharynx
Chapter 13 - Skin
End of Life Formulary
Wound Care Formulary
Traffic light list for prescribing
Position Statements
Cannabis Products MSEMOC Position Statement
Chronic Fatigue Syndrome (CFS) or myalgic encephalomyelitis (ME)
Controlled Drugs on repeat Templates
Co-proxamol is not supported for acute of chronic pain
Dental Preparations MSEMOC Position Statement
Dupilumab for treating Chronic Rhinosinustis with Nasal Polyps MSEMOC Position Statement
Emollients Prescribing Guidance
Fentanyl Immediate Release Preparation MSEMOC Position Statement
Glucosamine for osteoarthritis
Good practice for paracetamol prescribing
Length of repeat prescription supply
Liothyronine MSEMOC Position Statement
Low dose naltexone for the treatment of Multiple Sclerosis
Medicines that are Available for Purchase Over the Counter (Self Care)
Mexiletine (Namuscla) for the symptomatic treatment of myontonia in adults
Molludab for molluscum contagiosum
Multivitamins post bariatric surgery MSEMOC Position Statement
Oxycodone and Naloxone MSEMOC Position Statement
PDE5 Inhibitors for the Treatment of Erectile Dysfunction
Pigmanorm cream for the treatment of melasma
Sodium hyaluronate for osteoarthritis
Tramadol and paracetamol MSEMOC Position Statement
Transfer of Prescriptions from Private to NHS
Prescribing for Patients abroad during Coronavirus
Vitamin D for supplemention insufficiency and maintenance doses MSEMOC Position Statement
Shared Care Guidelines
Prescribing Incentive Scheme
Prescribing Newsletters
Patient Information
Over the counter patient information Sheet
Easy read over the counter leaflet
Over the counter leaflet print ready
Prescribing changes from December 2017
Changes to co proxamol prescribing
Changes to dosulepin prescribing
Changes to doxazosin prescribing
Changes to glucosamine prescribing
Changes to herbal treatment prescribing
Changes to homeopathy prescribing
Changes to immediate release fentanyl prescribing
Changes to lidocaine plaster prescribing
Changes to liothyronine prescribing
Changes to lutein and antioxidant supplements prescribing
Changes to omega 3 fatty acids prescribing
Changes to once daily tadalafil prescribing
Changes to perindopril arginine prescribing
Changes to rubefacients prescribing
Changes to TarginactA prescribing
Changes to TramacetA prescribing
Changes to travel vaccines prescribing
Changes to trimipramine prescribing
Braltus Zonda patient Information leaflet
Erectile Dysfunction Patient Information Leaflet
